Cathay Gross Profit vs Total Revenue Analysis
688065 Stock | 45.01 0.36 0.79% |
Cathay Biotech financial indicator trend analysis is way more than just evaluating Cathay Biotech prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Cathay Biotech is a good investment. Please check the relationship between Cathay Biotech Gross Profit and its Total Revenue accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cathay Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
Gross Profit vs Total Revenue
Gross Profit vs Total Revenue Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Cathay Biotech Gross Profit account and Total Revenue. At this time, the significance of the direction appears to have weak contrarian relationship.
The correlation between Cathay Biotech's Gross Profit and Total Revenue is -0.08. Overlapping area represents the amount of variation of Gross Profit that can explain the historical movement of Total Revenue in the same time period over historical financial statements of Cathay Biotech, assuming nothing else is changed. The correlation between historical values of Cathay Biotech's Gross Profit and Total Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Gross Profit of Cathay Biotech are associated (or correlated) with its Total Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Revenue has no effect on the direction of Gross Profit i.e., Cathay Biotech's Gross Profit and Total Revenue go up and down completely randomly.
Correlation Coefficient | -0.08 |
Relationship Direction | Negative |
Relationship Strength | Insignificant |
Gross Profit
Gross profit is a required income statement account that reflects total revenue of Cathay Biotech minus its cost of goods sold. It is profit before Cathay Biotech operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Total Revenue
Total revenue comprises all receipts Cathay Biotech generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Most indicators from Cathay Biotech's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Cathay Biotech current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cathay Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. The current year's Tax Provision is expected to grow to about 56.8 M, whereas Selling General Administrative is forecasted to decline to about 83.2 M.
2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 16.3M | 20.0M | 32.2M | 19.7M | Interest Income | 213.3M | 236.8M | 219.8M | 156.9M |
Cathay Biotech fundamental ratios Correlations
Click cells to compare fundamentals
Cathay Biotech Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Currently Active Assets on Macroaxis
Other Information on Investing in Cathay Stock
Balance Sheet is a snapshot of the financial position of Cathay Biotech at a specified time, usually calculated after every quarter, six months, or one year. Cathay Biotech Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Cathay Biotech and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Cathay currently owns. An asset can also be divided into two categories, current and non-current.